期刊文献+

我院2014年上半年住院科室糖皮质激素使用情况调查分析 被引量:1

Analysis on prescriptions of glococorticoid drugs for inpatients
原文传递
导出
摘要 目的分析住院患者糖皮质激素使用情况,为临床管理和合理用药提供参考.方法以专业用药指南和药品说明书为依据,利用合理用药监测系统(PASS)系统对我院2014年1月-6月上半年使用糖皮质激素的住院患者的病历进行分析点评,将点评结果和数据进行分析.结果上半年所有出院患者中糖皮质激素使用率为22.97%,其中内科各病房的使用率较高.使用量排名前5位的依次为氢化可的松、布地奈德雾化液、甲泼尼松琥珀酸钠、地塞米松注射液、泼尼松片.给药途径前三名分别为静脉或肌注占98.02%,雾化吸入占33.07%,外用占7.71%.我院糖皮质激素的使用剂量和频次均未超过我院规定的限定日剂量.结论糖皮质激素临床应用随意性较大,存在用药不合理的地方,需要对糖皮质激素的临床应用加强管理. Objective To analyze of the prescriptions of glococorticoid drugs for inpatients and provide evidence for rational clinical medication.Methods.Based on professional medication guide and the drug instructions,all the medical records with glucocorticoid prescription in first half of 2014 were selected and analyzed by prescription automatic screening system(PASS).Results The overall rate of glucocoricoid prescription was 22.97%in all inpatients,in which internal medical departments accounted for the most.Hydrocortisone,budesonide,methylprednisolone sodium succinate,dexamethasone and prednisone were the five most frequently used medicine.The most common administration route as follows:Intravenous or intramuscular injection(98.2%),aerosol inhalation(3307%)and external use(7.71%).The dosage and frequency were properly controlled under dose-limiting.Conclusion Strengthening management is required for the unreasonable prescriptions of glucocorticoid use.
作者 张岩 ZHANG Yan(Department of Pharmacy,Tianjing Hongqiao Hospital,Tianjing 300131,China)
出处 《山东大学学报(医学版)》 CAS 北大核心 2014年第S02期108-111,共4页 Journal of Shandong University:Health Sciences
关键词 糖皮质激素 住院患者 合理药物使用 Glucocorticoid Inpatients Good clinical practice
  • 相关文献

参考文献4

二级参考文献85

  • 1陈佳凤,陈恭平,郝淑华.盐酸溴己新与头孢拉定等九种药物配伍禁忌[J].时珍国医国药,2006,17(5):884-884. 被引量:3
  • 2胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
  • 3Stulnig TM, Waldhansl W. 11 beta-hydmxysteroid dehydrogenase type 1 in obesity and type 2 diabetes [ J ]. Diabetologia, 2004,47 (1) :1-11.
  • 4Eijken M, Hewison M, Cooper MS,et al. 1 lbeta-Hydroxysteroid de- hydrogenase expression and glucoeorticoid synthesis are directed by a molecular switch during osteoblast differentiation[ J]. Mol Endo- crino1,2005,19 ( 3 ) :621-631.
  • 5Wake D J, Walker BR. 11 beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome [ J ]. Mol Cell Endocrinol, 2004,215 ( 1/2 ) :45-54.
  • 6Wan SL, Liao MY, Sun K, et al. Postnatal development of 11 beta- hydmxysteroid dehydrogenase type 1 in the rat bippocampus[ J]. J Neurosci Res,2002,69 (5) :681-686.
  • 7Yan JL, Noble J, Kenyon C J, et al. Lack of tissue glucocorticoid re- activation in 11 beta-hydroxysteriod dehydrogenase type 1 knockout mice ameliorates age-related learning impairments [ J ]. Proe Natl Aead Sei U S A,2001,98(8) :4716-4721.
  • 8Mattsson C, Lai M, Noble J, et al. Obese Zucker rats have reduced mineralocortieoid receptor and 11 beta-hydroxysteroid dehydrogen- ase type 1 expression in hippocampus-implicatians for dysregulationof the hypothalamic-pituitary-adrenal axis in obesity [ J ]. Endocri- nology,2003 144(7) :2997-3003.
  • 9Kopelman PG. Obesity as a medical problem [ J ]. Nature, 2000, 404(6778 ) :635-643.
  • 10Baudrand R, Carvajal CA, Riquelme A, et al. Overexpression of 11 beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients[ J]. Obes Surg,2010,20( 1 ) :77-83.

共引文献47

同被引文献9

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部